BCLS II Investco, LP

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share
Latest Disclosed Shares Owned: 5,376,356 shares
Security Ownership %: 4.7%

BCLS Fund III Investments, LP ownership in NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share (NAMS)

04 Dec 2025 - BCLS Fund III Investments, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,376,356 shares of NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share (NAMS). This represents 4.7% ownership of the company. In their previous filing dated 07 Nov 2025, BCLS II Investco, LP had reported owning 11,422,504 shares, indicating a decrease of +53%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BCLS Fund III Investments, LP	4.7%	-53%	$214,462,841	5,376,356	-6,046,148	-53%	$39.89	13D/A	02 Dec 2025	04 Dec 2025, 16:30
BCLS Fund III Investments, LP	10%		$324,856,014	11,422,504			$28.44	13D/A	05 Nov 2025	07 Nov 2025, 19:19